Table 1 shows the reported mechanisms by which TNFα induces resistance to chemotherapy, radiotherapy, tyrosine kinase inhibitors, PARP inhibitors, trastuzumab and anti-immune checkpoint therapies in breast cancer. Here, TNF is linked to breast carcinoma.